Maxim Group downgraded Caladrius Biosciences (NASDAQ: CLBS) from Buy to Hold.Analyst Jason Kolbert commented:Caladrius announced their intention to discontinue the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE